Text Size

Urology Database to Evaluate Clinical Information and Improve Patient Care.

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
William Beaumont Hospitals
Information provided by (Responsible Party):
Kenneth Peters, MD, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00376298
First received: September 13, 2006
Last updated: November 9, 2012
Last verified: November 2012
History of Changes
  Purpose

The purpose of initiating the Urology Database is to evaluate the outcomes of urology procedures and medical management to enhance the care and treatment of urology patients.


Condition
Incontinence
Prostate Cancer
Interstitial Cystitis
Urinary Retention
Pelvic Organ Prolapse

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Urology Database for Outcomes Research

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by William Beaumont Hospitals:

Estimated Enrollment: 1000
Study Start Date: February 2004
Estimated Study Completion Date: February 2029
Estimated Primary Completion Date: February 2029 (Final data collection date for primary outcome measure)
Detailed Description:

The current study population will include all patients having had a radical prostatectomy for the treatment of prostate cancer, surgical prolapse repair as well as patients having had InterStim sacral nerve stimulator implantation. The database will house data extracted from the medical records. Patient demographics, and preoperative, intra-operative, postoperative, and follow-up clinical data will be collected.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

men and women with conditions below

Criteria

Inclusion Criteria:

All patients undergoing radical prostatectomy, pelvic organ prolapse repair and InterStim implantation at William Beaumont Hospital beginning January 1, 1998, as well as other urology patients as research questions are identified. Only patients who have accepted William Beaumont Hospital's Privacy Notices will be included in the database.

Exclusion Criteria:

Patients not acknowledging acceptance of William Beaumont Hospital's Privacy Notices.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00376298

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Kenneth Peters, MD
William Beaumont Hospitals
Investigators
Principal Investigator: Kenneth Peters, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00376298     History of Changes
Other Study ID Numbers: 2004-050
Study First Received: September 13, 2006
Last Updated: November 9, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
incontinence
prostate cancer
interstitial cystitis

Additional relevant MeSH terms:
Cystitis
Prolapse
Prostatic Neoplasms
Urinary Retention
Cystitis, Interstitial
Pelvic Organ Prolapse
Urinary Bladder Diseases
Urologic Diseases
 Pathological Conditions, Anatomical
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases
Urination Disorders

ClinicalTrials.gov processed this record on May 19, 2013